Robin L. Gabel
About Robin L. Gabel
Robin L. Gabel is an Executive Immuno-Oncology Specialist at Bristol-Myers Squibb in the Greater Philadelphia Area, with extensive experience in launching new indications for Immuno-Oncology agents and a deep understanding of the pharmaceutical industry.
Title
Robin L. Gabel holds the title of Executive Immuno-Oncology Specialist at Bristol-Myers Squibb in the Greater Philadelphia Area.
Company
Currently working at Bristol-Myers Squibb, Robin L. Gabel serves as an Executive Immuno-Oncology Specialist. Before this, Robin has held multiple roles within the same company, demonstrating extensive experience in various capacities. These roles include Executive Territory Business Manager from 2012 to 2015, Executive Transplant Specialist from 2010 to 2012, and Executive Territory Business Manager from 2005 to 2010.
Education and Expertise
Robin L. Gabel graduated from Brooklyn College with a Bachelor of Arts degree and attended Tilden High School. Possessing deep industry knowledge, Robin has experience in launching new indications for Immuno-Oncology agents such as Opdivo and Yervoy. This expertise extends to various types of cancers, including Non-Small Cell Lung Cancer, Renal Cell Carcinoma, and Metastatic Melanoma, among others.
Professional Background
Robin L. Gabel has built a robust career in the pharmaceutical industry with significant tenures at several companies. Starting as a Senior Institutional Sales Consultant at Pharmacia from 2001 to 2003 in Brooklyn, NY, Robin moved to positions at Cubist Pharmaceuticals and Biogen Idec before joining Bristol-Myers Squibb. With extensive experience working on the sales of Immuno-Oncology agents, Robin has worked closely with matrix teams, including Immuno-Oncology Specialists, Area Reimbursement Managers, and Medical Science Liaisons.
Achievements
Robin L. Gabel is noted for building long-term relationships with customers while maintaining a comprehensive understanding of products and competitors. In the role of Executive Immuno-Oncology Specialist, Robin is responsible for managing the sales of various Immuno-Oncology agents, leveraging a deep understanding of the buy and bill model within the pharmaceutical industry.